VALIDATION OF DAPT SCORE FOR PROLONGED DUAL ANTIPLATELET THERAPY IN ACUTE MYOCARDIAL INFARCTION PATIENTS
2018; Elsevier BV; Volume: 71; Issue: 11 Linguagem: Inglês
10.1016/s0735-1097(18)32652-4
ISSN1558-3597
AutoresDaniel Veron Esquivel, Fernando Batiz-Armenta, Aldo Cesar Cazares-Diazleal, Sandra Oviedo-Moguel, Sergio Martin Jarvio-Fernandez, Juan Manuel Arce-Gonzalez, Juan B. Ivey‐Miranda,
Tópico(s)Peripheral Artery Disease Management
ResumoDual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) reduces the rate of ischemic events but increases bleeding risk. DAPT score helps identify patients who benefit from prolonged DAPT, nevertheless its accuracy in patients with acute myocardial infarction (AMI) remains
Referência(s)